3/12
08:03 am
abbv
AbbVie (ABBV) had its "buy" rating reaffirmed by Guggenheim.
Low
Report
AbbVie (ABBV) had its "buy" rating reaffirmed by Guggenheim.
3/12
08:03 am
abbv
AbbVie (ABBV) had its "buy" rating reaffirmed by Guggenheim.
Low
Report
AbbVie (ABBV) had its "buy" rating reaffirmed by Guggenheim.
3/9
01:06 pm
abbv
AbbVie (ABBV) had its "outperform" rating reaffirmed by William Blair.
Low
Report
AbbVie (ABBV) had its "outperform" rating reaffirmed by William Blair.
3/9
01:06 pm
abbv
AbbVie (ABBV) had its "outperform" rating reaffirmed by William Blair.
Low
Report
AbbVie (ABBV) had its "outperform" rating reaffirmed by William Blair.
3/9
11:05 am
abbv
AbbVie (ABBV) had its "outperform" rating reaffirmed by BMO Capital Markets.
Low
Report
AbbVie (ABBV) had its "outperform" rating reaffirmed by BMO Capital Markets.
2/26
06:27 am
abbv
AbbVie (ABBV) was upgraded by Royal Bank Of Canada to "moderate buy".
Low
Report
AbbVie (ABBV) was upgraded by Royal Bank Of Canada to "moderate buy".
2/26
06:27 am
abbv
AbbVie (ABBV) was upgraded by Royal Bank Of Canada to "moderate buy".
Low
Report
AbbVie (ABBV) was upgraded by Royal Bank Of Canada to "moderate buy".
2/25
09:50 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
2/25
09:50 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
2/24
04:12 pm
abbv
AbbVie initiated with an Outperform at RBC Capital
Low
Report
AbbVie initiated with an Outperform at RBC Capital
2/24
04:12 pm
abbv
AbbVie initiated with an Outperform at RBC Capital
Low
Report
AbbVie initiated with an Outperform at RBC Capital
2/21
06:31 am
abbv
AbbVie (NYSE:ABBV) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Low
Report
AbbVie (NYSE:ABBV) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
2/20
09:34 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
2/20
09:34 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
2/19
08:01 pm
abbv
AbbVie (NYSE:ABBV) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Low
Report
AbbVie (NYSE:ABBV) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
2/19
04:17 pm
abbv
AbbVie initiated with an Overweight at Barclays
Low
Report
AbbVie initiated with an Overweight at Barclays
2/19
04:17 pm
abbv
AbbVie initiated with an Overweight at Barclays
Low
Report
AbbVie initiated with an Overweight at Barclays
2/12
06:37 am
abbv
AbbVie (NYSE:ABBV) was upgraded by analysts at UBS Group AG to a "hold" rating.
Low
Report
AbbVie (NYSE:ABBV) was upgraded by analysts at UBS Group AG to a "hold" rating.
2/5
10:59 am
abbv
AbbVie (NYSE:ABBV) had its "market perform" rating reaffirmed by analysts at Sanford C. Bernstein.
Low
Report
AbbVie (NYSE:ABBV) had its "market perform" rating reaffirmed by analysts at Sanford C. Bernstein.
2/5
10:26 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
2/5
09:21 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
2/5
08:23 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
2/5
08:23 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
2/4
03:10 pm
abbv
AbbVie (NYSE:ABBV) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
AbbVie (NYSE:ABBV) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
2/4
03:10 pm
abbv
AbbVie (NYSE:ABBV) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
AbbVie (NYSE:ABBV) had its "outperform" rating reaffirmed by analysts at Evercore ISI.